Accentia Biopharmaceuticals
Accentia enters into definitive deal for a $25 million financing
Published in Medical Verdicts and Law Weekly, November 2nd, 2006
Funding was completed on October 2, 2006. Rodman & Renshaw, LLC acted as the sole placement agent for the financing. The proceeds will be used to strengthen the company's cash position, repay certain short-term debt, support commercialization of its specialty pharmaceuticals business and develop intranasal antifungals for chronic sinusitis.
The debenture offering provides investors with an 8% coupon and 35% warrant coverage at an exercise price of $2.75 per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- ATS Medical
Theodore C. Skokos appointed to board of directors of cardiology devices company ATS Medical - Ajou University, South Korea
Study data from Ajou University, Department of Otolaryngology update knowledge of vertigo - Aperio Technologies
Aperio extends patent portfolio to encompass automated image analysis - Baylor College of Medicine, U.S.
Research on life sciences therapy published by scientists at Baylor College of Medicine, Department of Medicine - Body1
China issues its first online community patent to Body1 - Business Update
PDR Formulary Guide to health plan status on prescription products launched by Thomson - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
